Racial Differences in Genomic Profiles May Help Explain Breast Cancer Outcomes
Black patients with metastatic breast cancer were less likely than their White counterparts to have actionable genetic variations.
All articles by Jon Kelvey
Increase in Industry Payments to Oncologists Tied to Marketing of Checkpoint Inhibitors
The mean value of payments to oncologists increased over time, as did the percentage of oncologists accepting industry payments.
Racial Disparities Persist in Ovarian Cancer Treatment
Black race was significantly associated with not receiving a recommendation for chemotherapy.
Cancer Patients Have Higher Risk of Missed Payments, Collections, and Repossessions
Patients with cancer were 71% more likely than control individuals to experience an adverse financial event.
No Benefit Seen With Longer Antibiotic Course After Surgery for Bone Tumors
There were no significant differences between the treatment groups in rates of surgical site infections, unplanned operations, oncologic events, or all-cause mortality.
Giving Immune Checkpoint Inhibitors Within 90 Days of Radiation Appears Safe
Rates of adverse events were generally similar between patients who did and did not receive radiation.
Many Oncology Drugs Approved for Genomic Indications Not Studied for Overall Survival Outcomes
Overall survival data were available for about half of the drugs.
Analysis Reveals ‘Preferred’ Sequence of TNT for Organ Preservation in Locally Advanced Rectal Cancer
Chemoradiotherapy followed by consolidation chemotherapy resulted in a higher pathological complete response rate without compromising disease-free survival or increasing toxicity.
Multiple Myeloma Patients Face Increased Risk of COVID-19 Even When Vaccinated
Compared with patients who did not have cancer, patients with multiple myeloma had a higher risk of breakthrough SARS-CoV-2 infection.
Belzutifan Demonstrates Efficacy in VHL-Associated Renal Cell Carcinoma
Belzutifan demonstrated activity against both RCC and non-RCC neoplasms associated with VHL disease.
- Loading...
Loading...
Next post in Renal Cell Carcinoma
Loading... 
Loading...